Stockholders' Equity (Details) - USD ($)						1 Months Ended							3 Months Ended		12 Months Ended
	Dec. 26, 2021	Sep. 28, 2021	Aug. 24, 2021	Aug. 13, 2021	Aug. 12, 2021	Jul. 22, 2022	Jan. 19, 2022	Dec. 26, 2021	Aug. 24, 2021	Mar. 31, 2021	Feb. 28, 2021	Aug. 31, 2016	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Feb. 14, 2023	Jan. 06, 2023	Dec. 19, 2022	Oct. 14, 2022	Sep. 30, 2022	Jul. 26, 2021
Stockholders' Equity (Details) [Line Items]
Authorized capital stock (in Shares)													200,000,000
Common stock, shares authorized (in Shares)													180,000,000		180,000,000
Preferred stock shares authorized (in Shares)													20,000,000
Common stock for future issuances (in Shares)																					2,000,000
Stock split, description												In August 2016, the Company designated 1 share of Series A Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”) and has a stated value equal to $1.00 as may be adjusted for any stock dividends, combinations or splits. Each one (1) share of the Series A Preferred Stock shall have voting rights equal to (x) the total issued and outstanding Common Stock eligible to vote at the time of the respective vote divided by (y) forty-nine one hundredths (0.49) minus (z) the total issued and outstanding Common Stock eligible to vote at the time of the respective vote.
Authorizing the purchase																	$ 2,000,000
Common stock purchased value													$ 2,074		$ 2,060
Common stock price per share (in Dollars per share)													$ 0.0001		$ 0.0001				$ 1
Issued shares (in Shares)											100,000
Common stock fair value											$ 400,000		$ 100,000
Per share based on sales (in Dollars per share)										$ 0.7	$ 4
Stock based consulting														$ 50,000
Stockholders' Equity Note, Changes in Capital Structure, Subsequent Changes to Number of Common Shares (in Shares)														143,000
Net proceeds					$ 86,022
Additional shares issued, description								On December 26, 2021 and effective January 10, 2022, the Company approved the grant of 150,000 options to purchase the Company’s common stock to a newly hired employee of the Company.
Granted options term		5 years		5 years					5 years
Exercise price per share (in Dollars per share)		$ 4	$ 4	$ 1.25					$ 4
Granted aggregate options shares (in Shares)				215,000		325,000			75,000
Percentage of options vest		25.00%
Compensation expenses															$ 751,681
Stock-based expenses related to stock options													$ 154,542	$ 974,858
Common stock per share (in Dollars per share)													$ 0.5329
Unvested shares forfeited (in Shares)													178,750
Recognized stock-based compensation													$ 132,366
Professional fee													20,701
Remaining balance of stock based consulting													625,178
Compensation and other related expenses													1,549,692	1,674,730
Professional and consulting expenses													255,920	1,013,682
Unvested stock options issued													$ 1,637,196
Weighted average period													9 months 18 days
Aggregate intrinsic value of options outstanding													$ 0
Aggregate intrinsic value of warrants outstanding (in Shares)															0
Initial Public Offering [Member]
Stockholders' Equity (Details) [Line Items]
Purchase shares (in Shares)					3
Stock options [Member]
Stockholders' Equity (Details) [Line Items]
Percentage of options vest		25.00%													25.00%
Sale of Common Stock [Member]
Stockholders' Equity (Details) [Line Items]
Common stock shares (in Shares)													479,845
Common stock purchased value																				$ 311,174
Common stock price per share (in Dollars per share)													$ 0.648
Purchase shares (in Shares)																8,000,000
Granted options term	5 years
Exercise price per share (in Dollars per share)	$ 1.25	$ 4						$ 1.25
Options vest percentage			25.00%
Granted aggregate options shares (in Shares)							85,000
Sale of Common Stock [Member] | Stock options [Member]
Stockholders' Equity (Details) [Line Items]
Granted options term		5 years
Maximum [Member]
Stockholders' Equity (Details) [Line Items]
Common stock for future issuances (in Shares)																		3,000,000
Minimum [Member]
Stockholders' Equity (Details) [Line Items]
Common stock for future issuances (in Shares)																		2,000,000
Sale of Common Stock [Member]
Stockholders' Equity (Details) [Line Items]
Purchase shares (in Shares)					13,978
Stock options [Member]
Stockholders' Equity (Details) [Line Items]
Granted options term
Compensation and other related expenses													$ 603,278	822,583
Professional and consulting expenses													$ 21,900	$ 152,275